A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): Evidence for reduced neonatal morbidity

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 122, Issue 1, 2015, Pages 71-79

  Awwad, J ^a   Usta, I M ^a   Ghazeeri, G ^a   Yacoub, N ^a   Succar, J ^a   Hayek, S ^a   Saasouh, W ^a   Nassar, A H ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

17 Alpha hydroxyprogesterone caproate; preterm birth; prevention; progestogens; twin gestation

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PLACEBO; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; GESTAGEN; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORBIDITY; NEWBORN SEPSIS; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; TWIN PREGNANCY; VERY LOW BIRTH WEIGHT; INTRAMUSCULAR DRUG ADMINISTRATION; PREGNANCY; PREMATURE BIRTH; PREMATURITY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY; RISK; SECOND TRIMESTER PREGNANCY; SEPSIS; THIRD TRIMESTER PREGNANCY;

ADULT; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INJECTIONS, INTRAMUSCULAR; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREGNANCY, TWIN; PREMATURE BIRTH; PROGESTINS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY; SEPSIS;

EID: 84919959062     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13031     Document Type: Article

References (35)

1. Büscher U, Horstkamp B, Wessel J, Chen FCK, Dudenhausen JW,. Frequency and significance of preterm delivery in twin pregnancies. Int J Gynaecol Obstet 2000; 69: 1-7.
2. de la Torre L, Istwan NB, Desch C, Rhea DJ, Roca L, Stanziano GJ, et al. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis. Am J Perinatol 2008; 25: 555-60.
3. Stock S, Norman J,. Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med 2010; 15: 336-41.
4. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in neonatal mortality-United States. MMWR Morb Mortal Wkly Rep 2004; 53: 655-8.
5. Astle S, Slater DM, Thornton S,. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108: 177-81.
6. Loudon JA, Elliott CL, Hills F, Bennett PR,. Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 2003; 69: 331-7.
7. Da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M,. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-24.
8. Fonseca EB, Celik E, Parra M, Singh M,. Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-9.
9. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
10. Romero R, Nicolaides K, Conde-Agudo A, Tabor A, O'Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206: 124.e1-19.
11. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-85.
12. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007; 357: 454-61.
13. Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, et al. Progesterone does not prevent preterm births in women with twins. South Med J 2009; 102: 900-4.
14. Combs CA, Garite T, Maurel K, Das A, Porto M,; Obstetrix Collaborative Research Network. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2011; 204: 221.e1-8.
15. Nassar AH, Usta IM, Rechdan JB, Harb TS, Adra AM, Abu-Musa AA,. Pregnancy outcome in spontaneous twins versus twins who were conceived through in vitro fertilization. Am J Obstet Gynecol 2003; 189: 513-18.
16. Caritis SN, Sharma S, Venkataramanan R, Rouse DJ, Peaceman AM, Sciscione A, et al. Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. Am J Obstet Gynecol 2011; 205: 40.e1-8.
17. Senat M, Porcher R, Winer N, Vayssière C, Deruelle P, Capelle M, et al. Prevention of preterm delivery by 17 alpha-hydroxyproge-sterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. Am J Obstet Gynecol 2013; 208: 194.e1-8.
18. Caritis SN, Simhan HN, Zhao Y, Rouse DJ, Peaceman AM, Sciscione A, et al. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. Am J Obstet Gynecol 2012; 207: 396.e1-8.
19. Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, et al. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. BJOG 2013; 120: 50-7.
20. Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, et al. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial. Obstet Gynecol 2011; 118: 513-20.
21. Rode L, Klein K,. Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011; 38: 272-80.
22. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034-40.
23. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A,. Progesteroneeffects on preterm birth in high-risk pregnancies: a randomized placebo controlled trial. Arch Gynecol Obstet 2011; 283: 423-9.
24. Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A,; PREDICT Group. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. Ultrasound Obstet Gynecol 2011; 38: 281-7.
25. DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007; 30: 697-705.
26. Conde-Agudelo A, Romero R, Hassan SS, Yeo L,. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol 2010; 203: 128.e1-12.
27. Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, et al. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate. J Matern Fetal Neonatal Med 2010; 23: 1360-4.
28. Steinman G,. Difficulties in controlling and preventing preterm labor in multiple gestations: a clinical perspective. J Reprod Med 2010; 55: 143-6.
29. Lei K, Chen L, Cryar BJ, Hua R, Sooranna SR, Brosens JJ, et al. Uterine stretch and progesterone action. J Clin Endocrinol Metab 2011; 96: E1013-24.
30. Combs CA, Garite T, Maurel K, Das A, Porto M,; Obstetrix Collaborative Research Network. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2010; 203: 248.e1-9.
31. Dodd JM, Flenady VJ, Cincotta R, Crowther CA,. Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 2008; 112: 127-34.
32. Manuck TA, Lai Y, Meis PJ, Dombrowski MP, Sibai B, Spong CY, et al. Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2011; 205: 135.e1-9.
33. Ananth CV, Misra DP, Demissie K, Smulian JC,. Rates of preterm delivery among black women and white women in the United States over two decades: an age-period-cohort analysis. Am J Epidemiol 2001; 154: 657-65.
34. Aveyard P, Cheng KK, Manaseki S, Gardosi J,. The risk of preterm delivery in women from different ethnic groups. BJOG 2002; 109: 894-9.
35. Timofeev J, Singh J, Istwan N, Rhea D, Driggers RW,. Spontaneous preterm birth in African-American and Caucasian women receiving 17α-hydroxyprogesterone caproate. Am J Perinatol 2014; 31: 55-60.